Walgreens Boots Alliance
About: Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
Employees: 312,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
0% more funds holding in top 10
Funds holding in top 10: 4 [Q2] → 4 (+0) [Q3]
2.45% less ownership
Funds ownership: 61.6% [Q2] → 59.15% (-2.45%) [Q3]
6% less funds holding
Funds holding: 916 [Q2] → 861 (-55) [Q3]
10% less call options, than puts
Call options by funds: $246M | Put options by funds: $274M
18% less repeat investments, than reductions
Existing positions increased: 276 | Existing positions reduced: 337
29% less capital invested
Capital invested by funds: $6.43B [Q2] → $4.59B (-$1.84B) [Q3]
33% less first-time investments, than exits
New positions opened: 114 | Existing positions closed: 169
Research analyst outlook
8 Wall Street Analysts provided 1 year price targets over the past 3 months
8 analyst ratings
RBC Capital Ben Hendrix 25% 1-year accuracy 18 / 71 met price target | 6%downside $9 | Sector Perform Maintained | 4 Dec 2024 |
Jefferies Brian Tanquilut 54% 1-year accuracy 7 / 13 met price target | 6%downside $9 | Hold Maintained | 23 Oct 2024 |
TD Cowen Charles Ryhee 29% 1-year accuracy 2 / 7 met price target | 47%upside $14 | Buy Maintained | 22 Oct 2024 |
UBS Kevin Caliendo 56% 1-year accuracy 9 / 16 met price target | 5%upside $10 | Neutral Maintained | 17 Oct 2024 |
Barclays Steve Valiquette 75% 1-year accuracy 9 / 12 met price target | 16%downside $8 | Underweight Maintained | 16 Oct 2024 |
Financial journalist opinion
Based on 51 articles about WBA published over the past 30 days